secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0001493152-25-005923
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated Sciences CEO Mattacchione resigns effective Feb 20, 2025; stays Chairman
--------------------------------------------------------------------------------

- Robert Mattacchione's resignation as CEO extended to Feb 20, 2025 for orderly transition.
- He will remain Chairman of the Board and Chairman of subsidiary Novo Healthnet Limited.
- No successor CEO has been appointed; board searching to fill vacancy.
- Resignation is not due to any disagreement with the Company on operations or policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000149315225005923/0001493152-25-005923-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000149315225005923/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-005923

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer